This delivery approach is of particular interest for the potential treatment of patients with homozygous familial hypercholesterolemia (HoFH), a rare genetic disorder characterized by severe hepatic LDLR-deficiency13. Here, LDLR is linked to homozygous familial hypercholesterolemia.